Expert in vaccine epidemiology. Deputy Director General, @IVIheadquarter, Principal Research Associate at Dep Medicine @Cambridge_Uni, Prof at U. Antananarivo.
✨ Celebrating 15 yrs of partnership between @IVIHeadquarters & MIVR at @univtana!
✅ Advanced research in Madagascar 🇲🇬
✅ Created 100+ jobs for Malagasy researchers
✅ Established 2 research centers and labs
Thank you, team MIVR, donors, partners & Malagasy govt!
🇲🇬 In Madagascar's remote highlands lies Andina. Led by Prof. Raphaël Rakotozandrindrainy, a community-driven initiative now reaches 70,000 locals with essential services. The upgraded healthcare facility reshaped the health of the Andina population: https://t.co/92vkpNAGEA
Successful @IVIHeadquarters Kinshasa visit 🇨🇩. Meeting with @inrb_kinshasa, Korean🇰🇷 Embassy and Director of EPI Program. Discussed upcoming typhoid/iNTS disease conference (3-5 Dec 2024) in Kinshasa and plans for future malaria vaccine effectiveness studies. #VaccinesSaveLives
Congratulations to Professors Holmgren, Graham and McLellan to receive the prestigious 2024 IVI-SK bioscience Park MahnHoon Award for their groundbreaking research on vaccines for global health. https://t.co/V7gexZ8JIP
🇧🇹 Bhutan's 8th Intl Conference on Medical & Health Sciences that focused on transforming health systems for equity & resilience, featuring global health leaders took place from April 11-13 in Thimphu. #ICMH2024#HealthEquity
🌏 Exciting workshop update! This week, the Hong Kong Jockey Club Global Health Institute hosted a workshop with experts from @IVIHeadquarters, @HKUMedicine, & @Cambridge_Uni. We're forging ahead in pandemic readiness, health economics, vaccine development & more!
There are ~12.5 to 16.3 million cases of #typhoid every year with ~140,000 deaths
However, with generic symptoms and the need for blood culture sampling to make a definitive diagnosis, it is difficult for governments to capture the true burden of typhoid in their countries
📢 NEW research in @LancetGH shows a high burden of #typhoid fever in sub-Saharan African countries, indicating need for introduction of typhoid conjugate vaccines in endemic countries
Results from IVI's 4-year Severe Typhoid in Africa (SETA) program ⤵️
https://t.co/wdBiRo8UHs
🌏 INDO-PACIFIC CLIMATE RESILIENCE FORUM in Antananarivo Nov 20/21. 🌊 Exciting discussions with participants from 🇲🇿🇲🇼🇫🇯 🇵🇪🇬🇲 🇲🇺. Day 1 highlighted challenges and strategies. Kudos to @IVIHeadquarters / MIVR team! 🙌 #ClimateForum. More: https://t.co/xqN6GF0BKt
Schistoshield® Phase 1b trial initiated in Madagascar, marking a crucial step in the development of a schistosomiasis vaccine. Global consortium supports efforts to combat this widespread disease. https://t.co/RtKURhuzHH, https://t.co/KHc8xjXJ7D
The Memorandum of understanding to establish the Hong Kong Jockey Club Global Health Institute signed (Nov 15). A collaboration between @IVIHeadquarters, @hkumed, @Cambridge_Uni, and @HKJC_Racing for cutting-edge pandemic preparedness. #GlobalHealth 🌍
At the #GTFCC and listening to countries describing the successes and challenges of implementing cholera control measures in this global crisis of cholera outbreaks. Champions all!
Many thanks to @CEPIvaccines for hosting this signing ceremony. This partnership builds upon previous successful collaborations between @IVIHeadquarters and CEPI, from before and especially during the pandemic.
We’re looking forward to this next phase: https://t.co/VntPn32ntc